共 45 条
[1]
Apicella M(2020)COVID-19 in people with diabetes: understanding the reasons for worse outcomes Lancet Diabetes Endocrinol 8 782-792
[2]
Campopiano MC(2020)Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study BMJ 369 1645-1653
[3]
Mantuano M(2021)Safety, tolerablity, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial Lancet Infect Dis 21 1443-1454
[4]
Li Y(2020)The clinical characteristics and outcoumes of patients with diabetes and secondary hyperglycemia with coronavirus disease 2019: a single-center, retrospective, observational study in Wuhan Diabetes Obes Metab 22 109022-6507
[5]
Teng D(2021)Short-term safety profile of SARS-CoV2 vaccination on glucose control: continuous glucose monitoring data in people with autoimmune diabetes Diabetes Res Clin Pract 179 101412-319
[6]
Shi X(2020)ASIA syndrome and endocrine autoimmune disorders Best Pract Res Clin Endocrinol Metab 34 460-770
[7]
Han B(2021)Rate and predictors of hesitancy toward SARS-CoV-2 vaccine among type 2 diabetic patients: results from an Italian survey Vaccines 9 6500-3246
[8]
Song Y(2020)Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine 38 318-446
[9]
Li C(2021)Sydney health literacy lab COVID-19 group. Willingness to vaccinate against COVID-19 in Australia Lancet Infect Dis 21 769-439
[10]
Zhang Y(2020)A future vaccinaion campaign against COVID-19 at risk of vaccine hesitancy and politicisation Lancet Infect Dis 20 3243-2805